Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) price on current trading day, rose 16.13% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.34.
A look at the stock’s price movement, the close in the last trading session was $2.02, moving within a range at $2.15 and $2.65. The beta value (5-Year monthly) was 1.497. Turning to its 52-week performance, $74.00 and $1.84 were the 52-week high and 52-week low respectively. Overall, BDRX moved -45.83% over the past month.
Biodexa Pharmaceuticals Plc ADR’s market cap currently stands at around $1.36 million, with investors looking forward to this quarter’s earnings report slated for in April.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BDRX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
BDRX’s current price about -18.03% and -38.03% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.56, while 7-day volatility ratio is 14.38% and 15.94% in the 30-day chart. Further, Biodexa Pharmaceuticals Plc ADR (BDRX) has a beta value of 1.61, and an average true range (ATR) of 0.50.
If we refocus on Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX), historical trading data shows that trading volumes averaged 6.61 over the past 10 days and 914.37K over the past 3 months. The company’s latest data on shares outstanding shows there are 0.36 million shares.
Also important is the data on short interest which shows that short shares stood at 36118.0 on 2025-02-28, giving us a short ratio of 0.03. The data shows that as of 2025-02-28 short interest in Biodexa Pharmaceuticals Plc ADR (BDRX) stood at 540.0 of shares outstanding, with shares short rising to 3244.0 registered in 2025-01-31. Current price change has pushed the stock -42.22% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BDRX stock continues to rise going into the next quarter.
